Analysts’ downgrades for Sunday, April 5th:
Alvotech (NASDAQ:ALVO) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.
BioXcel Therapeutics (NASDAQ:BTAI) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.
Creative Global Technology (NASDAQ:CGTL) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.
EIKN (NASDAQ:EIKN) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.
Ford Motor (NYSE:F) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.
International Seaways (NYSE:INSW) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
KalVista Pharmaceuticals (NASDAQ:KALV) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Merit Medical Systems (NASDAQ:MMSI) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
ON Semiconductor (NASDAQ:ON) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Oxford Industries (NYSE:OXM) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.
Koninklijke Philips (NYSE:PHG) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Pharvaris (NASDAQ:PHVS) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.
Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.
Rentokil Initial (NYSE:RTO) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Sanara MedTech (NASDAQ:SMTI) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Biosig Technologies (NASDAQ:STEX) was downgraded by analysts at Wall Street Zen from a hold rating to a strong sell rating.
Victoria’s Secret & Co. (NYSE:VSCO) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
